Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic disease, with no effective treatment and a median survival time of 2–5 yrs. The search for effective treatment has involved numerous clinical trials of investigational agents without significant success until 2011, when European approva...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2012-06-01
|
| Series: | European Respiratory Review |
| Subjects: | |
| Online Access: | http://err.ersjournals.com/content/21/124/161.full.pdf+html |